Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Appendicitis | 12 | 2021 | 946 | 2.93 | Why? |
| Appendectomy | 12 | 2021 | 585 | 1.48 | Why? |
| Laparoscopy | 10 | 2021 | 1532 | 1.35 | Why? |
| Colectomy | 3 | 2019 | 327 | 1.28 | Why? |
| Hidradenitis Suppurativa | 3 | 2019 | 309 | 1.17 | Why? |
| Anastomosis, Surgical | 4 | 2019 | 169 | 1.07 | Why? |
| Pancreaticoduodenectomy | 3 | 2019 | 60 | 1.01 | Why? |
| Ampulla of Vater | 2 | 2018 | 17 | 0.87 | Why? |
| Anastomotic Leak | 1 | 2019 | 46 | 0.78 | Why? |
| Anti-Bacterial Agents | 10 | 2021 | 10083 | 0.78 | Why? |
| Median Arcuate Ligament Syndrome | 1 | 2018 | 3 | 0.76 | Why? |
| Colon | 3 | 2019 | 669 | 0.76 | Why? |
| Onychomycosis | 1 | 2018 | 23 | 0.74 | Why? |
| Polysorbates | 1 | 2018 | 125 | 0.71 | Why? |
| Common Bile Duct Neoplasms | 1 | 2017 | 17 | 0.69 | Why? |
| Decompression, Surgical | 1 | 2018 | 114 | 0.68 | Why? |
| Skin Tests | 1 | 2018 | 229 | 0.66 | Why? |
| Robotic Surgical Procedures | 3 | 2019 | 787 | 0.62 | Why? |
| Drainage | 1 | 2019 | 414 | 0.60 | Why? |
| Rectum | 1 | 2019 | 495 | 0.60 | Why? |
| Nail Diseases | 1 | 2018 | 142 | 0.59 | Why? |
| Embolization, Therapeutic | 1 | 2018 | 269 | 0.59 | Why? |
| Intestinal Obstruction | 1 | 2018 | 197 | 0.58 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.56 | Why? |
| Goals | 1 | 2017 | 335 | 0.55 | Why? |
| Conservative Treatment | 1 | 2017 | 349 | 0.54 | Why? |
| Colonic Neoplasms | 1 | 2018 | 295 | 0.52 | Why? |
| Postoperative Care | 1 | 2019 | 755 | 0.52 | Why? |
| Dermatologic Agents | 1 | 2019 | 489 | 0.49 | Why? |
| Allergens | 1 | 2018 | 728 | 0.46 | Why? |
| Liver Cirrhosis, Biliary | 2 | 2004 | 42 | 0.45 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.45 | Why? |
| Pancreatic Neoplasms | 2 | 2019 | 609 | 0.42 | Why? |
| Acute Disease | 7 | 2019 | 6029 | 0.38 | Why? |
| Illusions | 2 | 2018 | 7 | 0.38 | Why? |
| Postoperative Complications | 7 | 2021 | 5861 | 0.37 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.34 | Why? |
| Monosomy | 1 | 2004 | 2 | 0.29 | Why? |
| Liver | 2 | 2018 | 4007 | 0.27 | Why? |
| Bile Acids and Salts | 3 | 2005 | 91 | 0.26 | Why? |
| Chromosomes, Human, X | 1 | 2004 | 81 | 0.26 | Why? |
| Thyroidectomy | 2 | 2017 | 207 | 0.26 | Why? |
| Hydroxycholesterols | 2 | 2005 | 85 | 0.25 | Why? |
| Sarcoma, Ewing | 2 | 2017 | 50 | 0.25 | Why? |
| Antibodies, Monoclonal | 2 | 2019 | 8041 | 0.24 | Why? |
| Bone Neoplasms | 3 | 2020 | 287 | 0.24 | Why? |
| Thyroid Diseases | 2 | 2017 | 285 | 0.22 | Why? |
| Benzyl Alcohol | 1 | 1999 | 1 | 0.21 | Why? |
| Clotrimazole | 1 | 1999 | 5 | 0.21 | Why? |
| Leg Dermatoses | 1 | 1999 | 20 | 0.21 | Why? |
| Appendiceal Neoplasms | 1 | 2019 | 7 | 0.20 | Why? |
| Appendix | 1 | 2019 | 10 | 0.20 | Why? |
| Sex Characteristics | 1 | 2008 | 1120 | 0.20 | Why? |
| Art Therapy | 1 | 2020 | 44 | 0.20 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.19 | Why? |
| Indocyanine Green | 1 | 2019 | 66 | 0.19 | Why? |
| Phytosterols | 1 | 1998 | 22 | 0.19 | Why? |
| Hepatic Artery | 1 | 2018 | 31 | 0.19 | Why? |
| Cisplatin | 2 | 2017 | 209 | 0.19 | Why? |
| Ganglia, Sympathetic | 1 | 2018 | 4 | 0.19 | Why? |
| Intradermal Tests | 1 | 2018 | 15 | 0.19 | Why? |
| Celiac Artery | 1 | 2018 | 13 | 0.19 | Why? |
| Neoplasms | 7 | 2020 | 17251 | 0.18 | Why? |
| Coloring Agents | 1 | 2019 | 116 | 0.18 | Why? |
| Terminally Ill | 1 | 2018 | 40 | 0.18 | Why? |
| Abdominal Injuries | 1 | 2019 | 72 | 0.18 | Why? |
| Thoracic Injuries | 1 | 2019 | 63 | 0.18 | Why? |
| Cholesterol | 2 | 1998 | 660 | 0.18 | Why? |
| Solutions | 1 | 2018 | 121 | 0.18 | Why? |
| Organ Sparing Treatments | 1 | 2018 | 91 | 0.18 | Why? |
| Cholecystectomy | 1 | 2020 | 198 | 0.18 | Why? |
| Injury Severity Score | 1 | 2018 | 287 | 0.17 | Why? |
| Duodenum | 1 | 2018 | 179 | 0.17 | Why? |
| Dreams | 1 | 2018 | 90 | 0.17 | Why? |
| Parathyroid Hormone | 1 | 2017 | 98 | 0.17 | Why? |
| Osteosarcoma | 1 | 2017 | 83 | 0.16 | Why? |
| Cholecystitis, Acute | 1 | 2020 | 234 | 0.16 | Why? |
| Mesenteric Veins | 1 | 2017 | 60 | 0.16 | Why? |
| Anesthetics, Local | 1 | 1999 | 205 | 0.16 | Why? |
| Dermatitis, Allergic Contact | 1 | 1999 | 185 | 0.16 | Why? |
| Humans | 53 | 2021 | 930598 | 0.16 | Why? |
| Hepatectomy | 1 | 2019 | 276 | 0.15 | Why? |
| Ileum | 1 | 2018 | 233 | 0.15 | Why? |
| Intestinal Perforation | 1 | 2018 | 178 | 0.15 | Why? |
| Hypocalcemia | 1 | 2017 | 120 | 0.15 | Why? |
| Abdomen | 1 | 2019 | 424 | 0.15 | Why? |
| Interleukin-2 | 1 | 2017 | 443 | 0.15 | Why? |
| Colonic Diseases | 1 | 2017 | 96 | 0.15 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.15 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2019 | 10649 | 0.15 | Why? |
| Colorectal Surgery | 1 | 2020 | 394 | 0.14 | Why? |
| Aorta | 1 | 2018 | 355 | 0.14 | Why? |
| Minimally Invasive Surgical Procedures | 2 | 2018 | 663 | 0.14 | Why? |
| Chemoradiotherapy | 1 | 2017 | 362 | 0.14 | Why? |
| Pancreas | 1 | 2018 | 398 | 0.14 | Why? |
| Portal Vein | 1 | 2017 | 193 | 0.14 | Why? |
| Hodgkin Disease | 1 | 2017 | 204 | 0.14 | Why? |
| Autoimmune Diseases | 1 | 2008 | 1996 | 0.14 | Why? |
| Dermoscopy | 1 | 2018 | 346 | 0.14 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.13 | Why? |
| Video-Assisted Surgery | 1 | 2013 | 43 | 0.13 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.13 | Why? |
| Drug Hypersensitivity | 1 | 1999 | 401 | 0.13 | Why? |
| Dermatologists | 1 | 2018 | 435 | 0.13 | Why? |
| Intestines | 1 | 2019 | 817 | 0.12 | Why? |
| Professional-Patient Relations | 1 | 2018 | 426 | 0.12 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.12 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.12 | Why? |
| Elective Surgical Procedures | 2 | 2021 | 5338 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.12 | Why? |
| Practice Patterns, Physicians' | 2 | 2021 | 4927 | 0.12 | Why? |
| Calcium | 1 | 2017 | 708 | 0.12 | Why? |
| Emergency Treatment | 1 | 2017 | 719 | 0.11 | Why? |
| Female | 27 | 2021 | 380317 | 0.10 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 1573 | 0.10 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.10 | Why? |
| Liver Neoplasms | 2 | 2019 | 1666 | 0.10 | Why? |
| Adult | 19 | 2021 | 244371 | 0.10 | Why? |
| Male | 24 | 2021 | 367725 | 0.10 | Why? |
| Italy | 8 | 2021 | 38444 | 0.10 | Why? |
| Antifungal Agents | 1 | 1999 | 1828 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Length of Stay | 4 | 2021 | 11042 | 0.09 | Why? |
| Fear | 2 | 2020 | 3607 | 0.09 | Why? |
| Melphalan | 1 | 2007 | 46 | 0.08 | Why? |
| Treatment Outcome | 7 | 2019 | 51732 | 0.08 | Why? |
| Antineoplastic Agents, Alkylating | 1 | 2007 | 71 | 0.08 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 9335 | 0.08 | Why? |
| Bone Marrow Neoplasms | 1 | 2007 | 60 | 0.08 | Why? |
| Tomography, X-Ray Computed | 3 | 2018 | 25144 | 0.08 | Why? |
| Surgeons | 1 | 2020 | 2233 | 0.08 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.07 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Doxorubicin | 2 | 2017 | 313 | 0.07 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.07 | Why? |
| Survival Analysis | 2 | 2017 | 7592 | 0.07 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.07 | Why? |
| Outpatients | 1 | 2017 | 3417 | 0.07 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.07 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2004 | 207 | 0.06 | Why? |
| Infection Control | 3 | 2021 | 23131 | 0.06 | Why? |
| Chenodeoxycholic Acid | 1 | 1982 | 9 | 0.06 | Why? |
| Schools | 1 | 2019 | 4187 | 0.06 | Why? |
| Deoxycholic Acid | 1 | 1982 | 17 | 0.06 | Why? |
| Aged | 13 | 2021 | 215776 | 0.06 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.06 | Why? |
| Ursodeoxycholic Acid | 1 | 1982 | 25 | 0.06 | Why? |
| Bile | 1 | 1982 | 56 | 0.06 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.06 | Why? |
| Cholelithiasis | 1 | 1982 | 47 | 0.06 | Why? |
| Adolescent | 11 | 2020 | 86841 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.05 | Why? |
| Sex Distribution | 1 | 2008 | 2083 | 0.05 | Why? |
| Students | 1 | 2019 | 5255 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Pancreatic Fistula | 1 | 2019 | 12 | 0.05 | Why? |
| Central Nervous System Neoplasms | 1 | 2020 | 88 | 0.05 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.05 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.05 | Why? |
| Sitosterols | 1 | 1998 | 7 | 0.05 | Why? |
| Duodenoscopy | 1 | 2018 | 12 | 0.05 | Why? |
| Hepatitis C | 2 | 2004 | 1514 | 0.05 | Why? |
| Intestinal Absorption | 1 | 1998 | 64 | 0.05 | Why? |
| Immune Tolerance | 1 | 2004 | 608 | 0.05 | Why? |
| Sex Factors | 2 | 2008 | 11014 | 0.05 | Why? |
| Rupture | 1 | 2018 | 40 | 0.05 | Why? |
| Ifosfamide | 1 | 2017 | 10 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.05 | Why? |
| Vinblastine | 1 | 2017 | 48 | 0.04 | Why? |
| Dacarbazine | 1 | 2017 | 67 | 0.04 | Why? |
| Blood Loss, Surgical | 1 | 2019 | 211 | 0.04 | Why? |
| Optical Imaging | 1 | 2019 | 197 | 0.04 | Why? |
| Operative Time | 1 | 2019 | 450 | 0.04 | Why? |
| Fluorescence | 1 | 2019 | 475 | 0.04 | Why? |
| Phosphorus | 1 | 2017 | 80 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Sarcoma | 1 | 2020 | 290 | 0.04 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.04 | Why? |
| Leukocytes | 1 | 2004 | 1046 | 0.04 | Why? |
| Bleomycin | 1 | 2017 | 195 | 0.04 | Why? |
| Child | 7 | 2020 | 70012 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Lymphoma | 1 | 2020 | 522 | 0.04 | Why? |
| Pain, Postoperative | 1 | 2019 | 289 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.04 | Why? |
| Stress, Physiological | 1 | 2019 | 378 | 0.03 | Why? |
| Adalimumab | 1 | 2018 | 389 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Delphi Technique | 1 | 2018 | 1257 | 0.03 | Why? |
| Hospital Administration | 1 | 2020 | 650 | 0.03 | Why? |
| Morbidity | 1 | 2019 | 1426 | 0.03 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2019 | 48226 | 0.03 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Chronic Disease | 1 | 2004 | 5139 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2004 | 4027 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2002 | 2523 | 0.02 | Why? |
| Emotions | 1 | 2020 | 2418 | 0.02 | Why? |
| Terminal Care | 1 | 2018 | 928 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Hepacivirus | 1 | 1997 | 1509 | 0.02 | Why? |
| Carcinoma, Hepatocellular | 1 | 1997 | 1222 | 0.02 | Why? |
| Deuterium | 1 | 2005 | 21 | 0.02 | Why? |
| Pedigree | 1 | 2007 | 502 | 0.02 | Why? |
| Emergencies | 1 | 2021 | 4095 | 0.02 | Why? |
| Genotype | 1 | 1997 | 4697 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.02 | Why? |
| Social Support | 1 | 2019 | 3183 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.02 | Why? |
| Recurrence | 1 | 2013 | 3675 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Age Factors | 1 | 2004 | 21039 | 0.02 | Why? |
| Drug Evaluation | 1 | 1982 | 100 | 0.01 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.01 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.01 | Why? |
| Communication | 1 | 2018 | 5206 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.01 | Why? |
| Pain | 1 | 2007 | 1084 | 0.01 | Why? |
| SARS Virus | 1 | 2002 | 13021 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2002 | 12361 | 0.01 | Why? |
| Animals | 1 | 2008 | 78931 | 0.01 | Why? |
| Patient Safety | 1 | 2013 | 4885 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2019 | 7301 | 0.01 | Why? |
| Lipid Metabolism | 1 | 1982 | 572 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Stress, Psychological | 1 | 2019 | 10231 | 0.01 | Why? |
| Lipids | 1 | 1982 | 1079 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2019 | 22116 | 0.01 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.01 | Why? |
| Double-Blind Method | 1 | 1982 | 5988 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 1982 | 7268 | 0.01 | Why? |
| Biomarkers, Tumor | 1 | 1997 | 1314 | 0.01 | Why? |
| Multivariate Analysis | 1 | 1997 | 5440 | 0.00 | Why? |
| Interferons | 1 | 1997 | 2885 | 0.00 | Why? |
| Viral Vaccines | 1 | 2002 | 7560 | 0.00 | Why? |
| Disease Outbreaks | 1 | 2002 | 27595 | 0.00 | Why? |
| Antiviral Agents | 1 | 1997 | 41703 | 0.00 | Why? |